Genomic analysis showed that alterations in p53, WNT–β-catenin, TGF-β, EGFR, and downstream MAPK/ERK and PI3K/Akt signaling pathways are associated with CRC tumorigenesis6. The gene discussed is TP53; the disease is colorectal carcinoma.